When was Ovagene founded?

Ovagene was founded in 2009 and raised its 1st funding round 3 years after it was founded.

Where is Ovagene located?

Ovagene is headquartered in Irvine, United States.

How many employees does Ovagene have?

As of Apr 30, 2026, the latest employee count at Ovagene is 6.

Is Ovagene a funded company?

Ovagene is a funded company, having raised a total of $2.12M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Mar 05, 2012.

When was the latest funding round of Ovagene?

Ovagene's latest funding was a $***** Seed round on Mar 12, 2012, with participation from 0 investor. Its primary sector is Genomics. In United States, the Genomics sector has seen $1.17B in funding in 2026 to date.

Where does Ovagene rank among its competitors?

Ovagene ranks 63rd amongst 57 active competitors, of which 17 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was DiamiR, which secured $9.46M in May, 2025.

Who are the top competitors of Ovagene?

Ovagene's top competitors include NGeneBio, DNA Electronics and Epigeneres. Among them, DiamiR secured the most recent funding round in May, 2025.

Ovagene - 2026 Company Profile, Team, Funding & Competitors

Ovagene is a deadpooled company based in Irvine (United States), founded in 2009 by William Rickets and Jay Coonan. It operates as a Diagnostic solutions for female reproductive cancers. Ovagene has raised $2.12M in funding. The company has 57 active competitors, including 17 funded and 10 that have exited. Its top competitors include companies like NGeneBio, DNA Electronics and Epigeneres.

Company Details

OvaGene Oncology develops and commercializes for female reproductive cancers. Its range of tests includes a chemotherapy drug response profile test, targeted therapy response profile, pharmacogenetic profile and next generation sequencing tests for ovarian, uterine, endometrial and cervical cancers.

Key Metrics

Founded Year

2009

Location

Irvine, United States

Stage

Deadpooled

Total Funding

$2.12M in 2 rounds

Latest Funding Round

Seed, Mar 12, 2012, $*****

Investors

TreeHouse Health

Ranked

63^rd among 90 competitors

Employee Count

6 as on Apr 30, 2026

Investment & Acquisitions

Etta

Similar Companies

NGeneBio & 86 more

View Ovagene's full profile

Ovagene has raised a total funding of $2.12M over 2 rounds. Its first funding round was on Mar 05, 2012. Ovagene has 1 institutional investor.

Here is the list of recent funding rounds of Ovagene:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 12, 2012	9338059	Seed	2953775	5436929	4654784	5736248
Mar 05, 2012	1974149	Seed	2257198	6682852	6224823	4629489

Access funding benchmarks and valuations. Sign up today!

View details of Ovagene's funding rounds and investors

The founders of Ovagene are William Rickets and Jay Coonan.

Here are the details of Ovagene's key team members:

William Rickets: Co-Founder & CSO of Ovagene.
Jay Coonan: Co-Founder & VP Business Development of Ovagene.

View details of Ovagene's Founder profiles and Board Members

Ovagene's employee count trend

Ovagene has 6 employees as of Apr 26. Here is Ovagene's employee count trend over the years:

Uncover Ovagene's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Ovagene include NGeneBio, DNA Electronics and Epigeneres. Here is the list of Top 10 competitors of Ovagene, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	NGeneBio 2015, Seoul (South Korea), Public	In vitro cancer diagnostic products	$12.9M	Korea Investment Holdings, IMM Investment ... & 3 others	56/100
2nd	DNA Electronics 2003, London (United Kingdom), Series C	Developer of semiconductor‑based DNA‑sequencing systems for use in healthcare	-	Citi, Genting Group & 1 others	54/100
3rd	Epigeneres 2008, Mumbai (India), Series B	Provider of genomics based diagnostic tests for cancer	$9.83M	Finessefabricrentals, LetsVenture & 54 others	52/100
4th	DotLab 2016, Branford (United States), Series A	Provider of a molecular diagnostic testing tool for endometriosis in women	$10M	CooperSurgical, Tiger Global Management & 6 others	49/100
5th	Crescendo Bioscience 2002, San Francisco (United States), Acquired	CLIA Laboratory focused on autoimmune and inflammatory diseases	$122M	Calibrium, Kleiner Perkins & 7 others	47/100
6th	Syrona Health 2018, Newcastle Upon Tyne (United Kingdom), Seed	Digital women's health management software for employers and individuals	$575K	Y Combinator, Fast Track Malmo & 19 others	46/100
7th	DiamiR 2009, Monmouth Junction (United States), Funding Raised	Developer of minimally invasive diagnostic tests	-	NIA, HHS	45/100
8th	Augurex 2006, Vancouver (Canada), Seed	Developer of diagnostic tests to detect autoimmune and chronic diseases	$978K	WUTIF Capital	45/100
9th	Provista Diagnostics 2007, New York City (United States), Acquired	Molecular oncology diagnostics company	$41.8M	Direct Strategy	44/100
10th	AccessDX 2016, Houston (United States), Unfunded	Provider of molecular diagnostic solutions and technologies	-	-	44/100
63rd	Ovagene 2009, Irvine (United States), Deadpooled	Diagnostic solutions for female reproductive cancers	$2.12M	TreeHouse Health	21/100